Affiliation:
1. Anuradha College of Pharmacy, Chikhli, Buldhana, India
Abstract
Mouth dissolving tablets are well established dosage forms available in the market. The numerous advantages that they offer to the patients in terms of compliance as well as to the manufacturers in terms of huge revenues by line extension of products are well known. In spite of such popularity, there seems to be lack of a standardized system to characterize these dosage forms. Enormous work has been done in this field, wherein some of the researchers have developed their own methods of evaluation. This article attempts to present a detailed review regarding technological advances made so far in the area of evaluation of mouth dissolving tablets with respect to special characteristics of these unique dosage forms. In the absence of any available standardized method, the author’s recommendation on critical issues in the field may be considered.
Reference33 articles.
1. Lindgren, S., & Janzon, L. (1991). Prevalence of swallowing complaints and clinical findings among 50-79-year-old men and women in an urban population. Dysphagia, 6, 187–192. doi:10.1007/BF02493524
2. Hanawa, T. (1995). New oral dosage form for elderly patients: Preparation and characterization of silk fibroin gel. Chemical and Pharmaceutical Bulletin, 43, 284–288. PMid:7728934
3. Gisel, E. G. (1994). Oral motor skills following sensorimotor intervention the moderately eating impaired child with cerebral palsy. Dysphagia, 9, 180–192. doi:10.1007/BF00341263
4. Virely, P., & Yarwood, R. (1990). Zydis - a novel, fast dissolving dosage form. Manufacturing Chemist, 61, 36–37.
5. Pebley, W. S., Jager, N. E., & Thompson, S. J. (1994, March 29). Rapidly disintegrating tablet. U.S. Patent 5,298,261.